伦敦, April 12, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences,一家推进糖尿病眼疾创新治疗的临床阶段生物技术公司,于今日宣布已在评估 VX-01 的第 2 期临床研究中成功完成首例患者的给药,VX-01 是治疗非增殖性糖尿病视网膜病变 (NPDR) 的一种口服疗法。
Posted: 2025-04-12 10:06:00

Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.
More News From This Category
Sun, 14 Sep 2025 22:07:46 +0000
Baltimore, MD, Sept. 14, 2025 (GLOBE NEWSWIRE) -- In a newly released interview, former CIA officer Buck Sexton has unveiled details of President Trump’s ambitious Artificial Superintelligence plan, what he calls “Manhattan 2.”
Read More ...
Sun, 14 Sep 2025 19:07:41 +0000
NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) -- MAGACOIN FINANCE, an Ethereum-based cryptocurrency project, today announced the expansion of its presale following consecutive rounds of rapid participation. The update comes as Cardano market commentary has begun including MAGACOIN FINANCE in early growth narratives, reflecting broader recognition of its momentum.
Read More ...
Sun, 14 Sep 2025 16:07:46 +0000
new york , Sept. 14, 2025 (GLOBE NEWSWIRE) -- New York City, NY, September 14, 2025, TestoPrime introduced an effective testosterone booster for men over 40s and 50s seeking a proven, safe, and powerful way to restore youthful energy, muscle, and vitality, a breakthrough solution has arrived.
Read More ...
Sun, 14 Sep 2025 13:07:42 +0000
New York, Sept. 14, 2025 (GLOBE NEWSWIRE) -- Optimove, the creator of Positionless Marketing and the #1 Player Engagement Platform for iGaming and sports betting operators, today announced rapid growth in the fast-expanding Social Sweepstakes Casinos sector. Since launching its dedicated Social Sweepstakes Casinos solutions in June 2024, Optimove has been chosen by leading operators,…
Read More ...
Sun, 14 Sep 2025 10:07:44 +0000
ASUNCIÓN, Paraguay, Sept. 14, 2025 (GLOBE NEWSWIRE) -- Ueno Bank, Paraguay’s largest bank with over 2.2 million customers, announced its transition to quantum-resistant cybersecurity to safeguard digital operations and digitally signed documents. Utilizing quantum-resistant digital signatures and quantum-resistant blockchain technology from SignQuantum and QANplatform, the implementation is being supported by ITTI, Paraguay’s leading technology company.
Read More ...